Grants-In-Aid: Cancer Center Intramural Grants
 
  • 2022 MCC COE Pilot Grant
    Moores Cancer Center Community Outreach and Engagement COE invites full and associate members, post-docs with an established member mentor, and early-stage investigators from the MCC consortium UC San Diego, San Diego State University, La Jolla Institute for Immunology to submit proposals for pilot awards to support catchment area priority cancer research. Expected return on investment is a successful K-series, R-series, or other similar extramural award as a result of preliminary data generated by pilot award support. Submissions are required to address one or more catchment area San Diego County priority cancers lung, breast, prostate, colorectal, pancreas, liver, leukemia, and HPV-driven cancers. Priority will be given to 1 Projects that focus on racial or ethnic groups and LGBTQ+ community, who are disproportionately impacted by the selected cancers 2 Projects that incorporate the community voice, through partnerships, advisors, or other means 3 Innovative new pilots, which can generate data supporting applications, especially those that are responsive to specific National Cancer Institute program announcements 4 Projects previously submitted but not awarded for extramural funding that would benefit from generation of additional preliminary data e.g., “near miss” K awards and R01s or submitted awards under review for which additional preliminary data are likely needed COE aims to reduce the cancer burden in the MCC catchment area by facilitating and catalyzing research that addresses this burden, particularly in priority cancers and by reducing cancer disparities. This RFA seeks applications that align with this aim in basic, clinical, translational, and/or population science research at any point along the cancer continuum. Success is measured by publications, submitted and funded R-series and K-series grants, changes in public policy, and community benefit to underserved populations.
    Read the full announcement here.
    Application deadline: 8/12/2022
    To start or continue the application process for this grant, click here.
     
  • 2022 LOI for Curebound Targeted Grant
    Curebound raises funds year-round for collaborative cancer research, including the signature event, Padres Pedal the Cause. Funds are available to faculty members from the 6 Curebound-affiliated institutions Moores MCC, Salk, Sanford Burnham Prebys SBP, Rady Children’s Hospital, La Jolla Institute LJI, and Scripps Research SR. The goal is to stimulate scientific collaboration, team science, and innovative translational research related to the prevention, diagnosis, or treatment of cancer or pre-cancer. A PI/Co-PI may submit only one 1 LOI for a Targeted Grant and/or 1 LOI for a Cure Prize in response to this Fall 2022 Curebound call. Targeted Grants Curebound will fund innovative translational oncology discoveries that show promise in advancing to pre-clinical and clinical stages. Targeted Grants will fund continuity of ideas from the investigators’ past lines of research, and this should be described in their research plan. Targeted Grants should include collaboration with at least one clinical researcher from UC San Diego Health or Rady Children’s Hospital. • Applicants will be invited to apply for a Targeted translational grant based on review of submitted LOIs. • $500,000 for a 1-year award
    Read the full announcement here.
    Application deadline: 8/15/2022
    To start or continue the application process for this grant, click here.
     
  • 2022 LOI for Curebound Cure Prize
    Curebound raises funds year-round for collaborative cancer research, including the signature event, Padres Pedal the Cause. Funds are available to faculty members from the 6 Curebound-affiliated institutions Moores MCC, Salk, Sanford Burnham Prebys SBP, Rady Children’s Hospital, La Jolla Institute LJI, and Scripps Research SR. The goal is to stimulate scientific collaboration, team science, and innovative translational research related to the prevention, diagnosis, or treatment of cancer or pre-cancer. A PI/Co-PI may submit only one 1 LOI for a Targeted Grant and/or 1 LOI for a Cure Prize in response to this Fall 2022 Curebound call. Cure Prize Prestigious award with a yearly challenge curated by the Curebound Scientific Advisory Board to fund innovative ground-breaking ideas that will change the course of cancer research and care in San Diego. Cure Prizes are given to teams who present collaborative and/or inter-disciplinary solutions that show near-term 3-5 years promise of clinical breakthrough and represent “game changers” in the prevention, treatment, and/or cure of cancer. Cure Prize Challenge An innovative solution that significantly improves the standard of care of a cancer that commonly leads to fatality. Solutions should have patient application within 3-5 years, if not sooner. Cure Prize research teams are intended to be collaborative either across institutions and/or across departments so solutions represent diverse and collaborative ideas. We encourage broad interpretation of this challenge and out-of-the-box thinking. Examples may include but are not limited to next generation sequencing NGS testing for populations that typically do not have access, a new therapy nearing toward clinical application, drug repurposing or combinations for new targets, etc. The intent of the Cure Prize is to fund innovative ground-breaking ideas that would change the course of cancer research and care in San Diego. • Applicants will be invited to apply for a Cure Prize based on Curebound Scientific review of submitted LOIs. • $1,000,000 for a 2- to 3-year award either $500,000/year for 2 years or $333,333/year for 3 years
    Read the full announcement here.
    Application deadline: 8/15/2022
    To start or continue the application process for this grant, click here.
     
  • 2022 Gleiberman Head and Neck Cancer Center Pilot Project Grant
    The UC San Diego Health Gleiberman Head and Neck Cancer Center is dedicated to providing support for the care of patients with head and neck cancer and their families. Our Center strives to provide effective, state of the art head and neck cancer care, as well as develop innovative, evidence-based approaches that facilitate novel therapies for head and neck cancer and a productive and healthy life for our patients and their families. The UC San Diego Health Gleiberman Head and Neck Cancer Center is seeking applications for pilot project grants under the Gleiberman Head and Neck Cancer Center Pilot Project Grant Award Program that will ultimately improve curative therapy as well as the quality of care for head and neck cancer patients and their families. Research proposals may be focused on any aspect of head and neck cancer care or head and neck and/or voice disease etiology, diagnosis, therapy. The Gleiberman Head and Neck Cancer Center is particularly interested in applications from investigators who have not previously been involved in translational head and neck cancer research, but whose fundamental research, possibly involving but not limited to cancer mechanisms or technology development, may be newly applied to head and neck cancer. Applications from junior investigators are also strongly encouraged.
    Read the full announcement here.
    Application deadline: 8/24/2022
    To start or continue the application process for this grant, click here.
     

 

Acrobat Reader must be installed to view pdf files.
Click the icon to the right to get a free copy.

Home  |  Events  |  Friends & Supporters  |  Faculty & Staff site |  Search

This site is a service of the Moores UCSD Cancer Center.  Comments or questions?  Please contact our webmaster.